routin
screen
lung
transplant
recipi
hospit
patient
respiratori
viru
infect
allow
identifi
human
rhinoviru
hrv
upper
lower
respiratori
tract
includ
immunocompromis
host
chronic
infect
strain
week
month
phylogenet
analysi
hrvposit
sampl
show
appar
correl
given
viral
genotyp
speci
abil
invad
lower
respiratori
tract
lead
protract
infect
contrast
protract
infect
found
almost
exclus
immunocompromis
patient
thu
suggest
host
factor
rather
viru
genotyp
modul
diseas
outcom
particular
immun
respons
complet
genom
sequenc
five
chronic
case
studi
rhinoviru
genom
adapt
show
calcul
mutat
frequenc
rang
observ
acut
human
infect
analysi
mutat
hot
spot
region
specimen
collect
differ
time
differ
bodi
site
reveal
nonsynonym
chang
mostli
concentr
viral
capsid
gene
independ
hrv
type
immunosuppress
lung
transplant
recipi
infect
hrv
strain
two
year
classic
ultradeep
sequenc
sampl
collect
differ
time
point
upper
lower
respiratori
tract
show
viru
popul
phylogenet
indistinguish
cours
infect
except
last
month
specif
signatur
found
last
two
lower
respiratori
tract
popul
includ
chang
polypyrimidin
tract
immunogen
site
result
highlight
first
time
abil
given
rhinoviru
evolv
cours
natur
infect
immunocompromis
patient
complement
data
obtain
previou
experiment
inocul
studi
immunocompet
volunt
human
rhinovirus
hrv
usual
caus
selflimit
upper
respiratori
tract
urt
ill
howev
increasingli
report
associ
complic
asthma
chronic
obstruct
pulmonari
diseas
copd
exacerb
pneumonia
bronchiol
young
children
hrv
abil
infect
lower
respiratori
tract
lrt
caus
chronic
infect
immunocompromis
host
unlik
enterovirus
rhinovirus
replic
optim
lower
airway
temperatur
thought
explain
urt
tropism
rhinoviru
strain
infect
lrt
may
requir
specif
adapt
genom
chang
yet
identifi
viral
infect
diseas
sever
result
close
interplay
viral
host
factor
host
immun
statu
known
play
critic
role
viral
clearanc
resolut
infect
abnorm
innat
immun
respons
hrv
observ
individu
present
hrvinduc
copd
asthma
exacerb
contrast
report
rare
implic
viral
determin
hrv
diseas
sever
palmemberg
et
al
propos
rhinoviru
polypyrimidin
tract
may
affect
virul
serotyp
speci
level
clear
associ
genotyp
induc
patholog
remain
demonstr
hrv
previous
classifi
two
speci
hrva
hrvb
third
speci
hrvc
identifi
appear
highli
preval
circul
worldwid
sever
studi
suggest
hrvc
type
prone
induc
sever
ill
children
due
errorpron
rna
polymeras
rna
virus
subject
constant
evolut
error
rate
picornaviru
rna
polymeras
estim
rang
errorsnucleotidecycl
replic
variabl
drive
forc
viru
evolut
number
genera
speci
serotyp
illustr
divers
http
wwwpicornavirida
com
least
hrva
hrvb
serotyp
identifi
hrvc
type
propos
evolut
rhinovirus
well
character
serotyp
speci
level
littl
known
divers
gener
cours
natur
human
infect
sever
studi
investig
genom
variabl
enterovirus
vaccinederiv
poliovirus
chronic
infect
immunocompromis
patient
report
rhinovirus
group
analyz
recent
genom
evolut
experiment
immunocompet
human
infect
estim
vivo
mutat
frequenc
mutat
nucleotid
entir
open
read
frame
orf
fiveday
acut
infect
period
identifi
region
mutat
hot
spot
viral
capsid
gene
present
studi
perform
first
phylogenet
analysi
compar
rel
distribut
hrv
speci
serotyp
accord
respiratori
site
urt
versu
lrt
protract
infect
hospit
patient
lung
transplant
recipi
latter
group
evalu
frequenc
mutat
character
mutat
hot
spot
region
cours
five
natur
human
protract
infect
caus
differ
rhinoviru
serotyp
one
case
follow
intrahost
rhinoviru
genom
variat
differ
time
point
urt
lrt
period
month
use
classic
ultradeep
sequenc
method
written
inform
consent
obtain
individu
prior
studi
particip
studi
approv
institut
review
board
univers
geneva
hospit
clinic
specimen
extract
hcv
amplicor
specimen
prepar
kit
roch
rotkreuz
switzerland
trizol
invitrogen
carlsbad
ca
usa
easymag
geneva
switzerland
accord
manufactur
instruct
revers
transcript
rt
realtim
pcr
primer
probe
assay
perform
previous
describ
picornavirusposit
sampl
detect
patient
enrol
cohort
lung
transplant
recipi
septemb
novemb
hospit
patient
screen
routin
laboratori
univers
geneva
hospit
februari
novemb
tabl
complet
genom
sequenc
obtain
lrt
urt
sampl
five
chronicallyinfect
individu
collect
differ
time
point
cours
infect
fragment
amplifi
pcr
use
degener
primer
design
anneal
highlyconserv
sequenc
correspond
hrv
refer
strain
overlap
fragment
assembl
necessari
specif
nondegener
primer
design
fill
gap
origin
pcr
product
primer
use
studi
list
tabl
pcr
primer
seminest
pcr
primer
tabl
perform
sequenc
pcr
product
purifi
microcon
column
millipor
zug
switzerland
sequenc
pcr
product
sequenc
least
twice
nucleotid
chang
confirm
second
pcr
sequenc
chromatogram
produc
abi
prism
dna
sequenc
appli
biosystem
pe
europ
bv
basel
switzerland
directli
import
proofread
geneiou
pro
softwar
biomatt
ltd
auckland
new
zealand
sequenc
avail
genbank
access
number
align
construct
use
muscl
maximum
iter
multipl
fasta
convert
phylip
format
treebuild
emboss
program
seqret
tree
built
phyml
use
gtr
model
bionj
initi
tree
optim
tree
topolog
branch
length
tree
fewer
speci
use
rate
categori
larger
tree
use
transitiontransvers
ratio
proport
invari
site
shape
paramet
alpha
gamma
distribut
estim
tree
process
includ
root
comput
support
valu
display
done
newick
util
statist
data
analys
carri
use
sasstat
softwar
version
sa
institut
inc
cari
nc
usa
associ
hrv
speci
infect
site
studi
cohort
evalu
use
chisquar
test
possibl
fisher
exact
test
expect
valu
smaller
urt
lrt
fulllength
sequenc
obtain
amplif
eight
overlap
nest
pcr
product
forward
revers
primer
tabl
rtpcr
assay
perform
duplic
discard
mutat
introduc
polymeras
error
use
platinium
taq
dna
polymeras
high
fidel
invitrogen
pcr
accord
manufactur
instruct
amplicon
purifi
microcon
column
millipor
sequenc
eight
overlap
pcr
pool
equimolar
concentr
use
ultradeep
sequenc
individu
sampl
sampl
librari
prepar
accord
manufactur
protocol
illumina
inc
san
diego
ca
usa
use
index
adapt
design
fasteri
fasteri
sa
planlesou
switzerland
see
method
genom
analyz
run
librari
pool
sequenc
illumina
genom
analyz
gaiix
illumina
singleread
channel
cycl
use
version
sequenc
kit
perform
basecal
use
illumina
pipelin
rta
casava
produc
million
pass
filter
read
attribut
unambigu
base
bioinformat
data
analys
map
perform
use
maq
softwar
version
http
maqsourceforg
netmaqmanshtml
averag
read
map
urt
consensu
sequenc
sampl
analyz
mean
coverag
read
per
nucleotid
map
result
use
extract
list
singl
nucleotid
polymorph
snp
throughout
genom
see
supplementari
method
bioinformat
data
analys
mutat
analysi
along
whole
hrv
genom
densiti
mutat
repres
gaussian
kernel
densiti
function
use
smooth
band
width
kernel
standard
deviat
curv
shown
scale
normal
valu
highest
densiti
found
genom
graph
includ
kernel
estim
produc
r
statist
packag
hrv
orf
amino
acid
conserv
plot
conserv
plot
comput
emboss
packag
plotcon
program
use
default
paramet
except
slide
window
size
set
aa
program
use
text
mode
comput
mean
standard
deviat
report
previous
three
case
patient
chronic
infect
uniqu
rhinoviru
strain
sinc
identifi
two
addit
similar
case
five
patient
immunocompromis
lung
transplant
recipi
infect
urt
lrt
tabl
three
infect
hrva
speci
two
hrvb
speci
genotyp
strain
found
nasopharyng
specimen
urt
bronchoalveolar
lavag
fluid
lrt
strain
identifi
case
infect
last
three
week
protract
infect
assess
whether
member
hrva
b
c
speci
equal
repres
lrt
andor
case
protract
infect
sampl
collect
prospect
cohort
lung
transplant
recipi
screen
routin
septemb
novemb
well
hospit
patient
screen
routin
laboratori
univers
geneva
hospit
februari
novemb
tabl
sequenc
perform
posit
case
whenev
possibl
sequenc
obtain
hrvposit
specimen
collect
lung
transplant
recipi
cohort
specimen
collect
hospit
patient
children
adult
age
avail
phylogenet
analysi
perform
sequenc
obtain
well
correspond
sequenc
hrva
b
refer
type
propos
hrvc
refer
type
sequenc
sampl
repres
differ
infecti
episod
due
hrva
type
hrvb
type
hrvc
type
figur
figur
b
c
associ
observ
given
rhinoviru
speci
type
infect
urt
lrt
protract
upper
respiratori
tract
specimen
urt
nasopharyng
swab
aspir
lower
respiratori
tract
specimen
lrt
bronchoalveolar
lavag
fluid
partial
sequenc
case
report
previous
infect
whole
studi
popul
fisher
exact
test
p
hrva
c
present
similar
frequenc
among
lrt
infect
respect
lung
transplant
recipi
hospit
patient
figur
found
also
good
represent
differ
rhinoviru
serotyp
type
specimen
urt
lrt
protract
infect
figur
contrast
clear
associ
popul
studi
lung
transplant
recipi
versu
adult
pediatr
hospit
patient
type
infect
urt
lrt
protract
infect
fisher
exact
test
six
protract
infect
observ
five
lung
transplant
recipi
one
infant
final
observ
associ
infect
hrv
speci
patient
age
fisher
exact
test
proport
hrvc
posit
sampl
lrt
urt
protract
infect
significantli
higher
pediatr
hospit
patient
adult
hospit
patient
versu
respect
chisquar
figur
complet
genom
sequenc
obtain
differ
time
point
urt
andor
lrt
five
chronicallyinfect
lung
transplant
recipi
tabl
number
substitut
per
nucleotid
per
day
report
tabl
patient
except
sampl
collect
differ
time
point
avail
calcul
mutat
frequenc
rang
overlap
mutat
urt
lrt
found
five
patient
howev
superimposit
chang
along
refer
genom
figur
reveal
wherea
synonym
chang
distribut
along
genom
without
appar
specif
pattern
nonsynonym
mutat
cluster
mostli
capsid
gene
first
half
gene
gene
cold
spot
region
locat
viral
capsid
gene
well
three
chang
found
one
variat
hot
spot
observ
capsid
gene
similar
amino
acid
variabl
observ
among
hrv
refer
type
figur
genet
variat
extens
studi
patient
sever
sampl
avail
throughout
entir
infect
period
includ
sampl
collect
day
urt
lrt
phylogenet
tree
figur
perform
complet
genom
sequenc
show
urt
lrt
mutat
rate
slow
shortli
patient
death
viral
copyml
last
urt
lrt
respect
despit
high
viral
load
end
followup
period
may
account
overal
slower
mutat
rate
calcul
patient
compar
infect
shorter
period
tabl
last
three
sampl
collect
simultan
urt
lrt
analyz
high
throughput
sequenc
compar
variat
minor
popul
level
total
popul
minor
variant
present
lrt
month
persist
site
absent
correspond
urt
viral
popul
figur
similar
observ
made
major
variant
demonstr
genom
urt
figur
specif
synonym
chang
found
urt
lrt
sequenc
howev
nonsynonym
chang
observ
lrt
identifi
one
chang
polypyrimidin
tract
one
nonsynonym
chang
immunogen
site
one
nonsynonym
chang
protein
base
phylogenet
analysi
respect
frequenc
distribut
strain
infect
urt
lrt
reveal
appar
correl
given
hrv
serotyp
speci
abil
infect
lrt
lung
transplant
recipi
hospit
patient
hrva
c
strain
present
similar
propens
infect
lrt
hrvb
strain
found
associ
lrt
rel
small
number
infect
sampl
preclud
us
draw
firm
conclus
respect
previous
describ
chronic
lrt
hrvb
infect
studi
protract
infect
found
host
low
level
immun
mostli
lung
transplant
recipi
infant
result
suggest
host
factor
determin
diseas
outcom
rather
viru
type
five
lung
transplant
recipi
chronic
infect
hrv
period
time
rang
three
month
thu
allow
us
studi
intrahost
genet
variat
natur
chronic
infect
immunocompromis
host
complet
sangerbas
ultradeep
genom
sequenc
perform
differ
time
point
site
infect
mutat
map
along
hrv
genom
point
synonym
chang
roughli
spread
along
entir
orf
wherea
nonsynonym
chang
cluster
mostli
capsid
gene
capsid
gene
also
variabl
acut
infect
immunocompet
host
well
divers
among
hrv
refer
type
protein
form
outer
shell
virion
immun
pressur
explain
fast
evolut
local
mutat
hot
spot
gene
immunocompromis
host
may
appear
unexpect
howev
although
patient
highli
immunosuppress
time
transplant
immunosuppress
therapi
adapt
prevent
graft
reject
preserv
residu
cellular
humor
immun
may
account
observ
residu
immun
also
necessari
control
recoveri
viral
bacteri
infect
observ
patient
calcul
mutat
frequenc
occur
five
chronic
infect
caus
distinct
hrv
serotyp
variou
period
time
mutat
frequenc
differ
host
like
reflect
differ
viral
replic
level
differ
host
environ
differ
durat
infect
calcul
mutat
frequenc
rang
changentday
recent
data
genom
evolut
acut
experiment
infect
human
immunocompet
volunt
reveal
mutat
frequenc
changent
equival
chang
ntday
therefor
hrv
mutat
frequenc
observ
immunocompromis
host
infect
month
order
magnitud
observ
acut
infect
extens
analysi
rhinoviru
genom
modif
perform
case
one
patient
infect
two
year
strain
phylogenet
analysi
complet
genom
sequenc
includ
ultradeep
sequenc
perform
three
differ
time
point
reveal
urt
lrt
popul
phylogenet
indistinguish
prolong
period
time
either
covari
like
constant
viral
popul
mix
potenti
adapt
host
accumul
nonsynonym
chang
mainli
capsid
gene
viral
popul
appear
evolv
slowli
final
observ
signatur
put
adapt
lower
airway
condit
sever
month
infect
inde
last
two
lrt
popul
studi
present
specif
chang
polypyrimidin
tract
two
nonsynonym
chang
one
immunogen
site
second
protein
chang
absent
urt
popul
upon
appear
two
popul
remain
separ
confirm
ultradeep
sequenc
analysi
although
direct
impact
chang
viru
growth
abil
lower
airway
condit
remain
demonstr
experiment
high
viral
load
observ
stage
suggest
popul
adapt
site
taken
togeth
data
suggest
immunocompromis
patient
clear
viral
infect
immunocompet
individu
repres
potenti
reservoir
emerg
new
variant
interhost
transmiss
due
longer
chronic
viral
infect
addit
patient
may
coinfect
two
virus
thu
open
door
recombin
anoth
put
drive
forc
rhinoviru
evolut
emerg
new
therapi
progress
transplant
popul
immunocompromis
patient
constantli
increas
result
suggest
could
acceler
abil
virus
adapt
host
evolv
propag
may
favor
rapid
emerg
new
viral
variant
figur
repartit
protract
lower
respiratori
tract
infect
among
hrva
panel
hrvb
panel
b
hrvc
panel
c
refer
serotyp
cladogram
rhinovirus
isol
lung
transplant
recipi
blue
routin
screen
hospit
patient
red
tabl
well
hrva
panel
hrvb
panel
b
propos
hrvc
refer
type
black
panel
c
genbank
access
number
use
outgroup
lrt
pi
highlight
arrow
black
line
respect
pdf
tabl
sampl
collect
lung
transplant
recipi
cohort
sampl
hospit
patient
screen
routin
laboratori
univers
hospit
geneva
sampl
design
first
letter
famili
name
follow
last
two
number
birth
year
eg
month
year
sampl
collect
eg
site
sampl
u
upper
respiratori
tract
l
lower
respiratori
tract
tabl
primer
use
amplifi
sequenc
genom
clinic
strain
describ
tabl
method
ultradeep
sequenc
analysi
doc
